SUBSTITUTED INDOLES FOR MODULATING NFKB ACTIVITY
03-05-2001 дата публикации
Номер:
WO2001030774A1
Принадлежит: Aventis Pharma Deutschland GmbH
Контакты:
Номер заявки: EP0010210
Дата заявки: 17-10-2000
The invention relates to compounds of formula (I) which are suitable for the production of medicaments for the prophylaxis and treatment of disease states, the course of which involves increased NFkB activity. The compounds are specific IkB-kinase inhibitors.[1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31][32]